FdaApplication
ANDA 202321
Identifiers
- fda_app_no: ANDA202321
Properties
| Property | Value |
|---|---|
| applicant_name | SPECGX LLC |
| application_type | ANDA |
| approval_date | 2013-04-25 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | 5MG | TABLET;ORAL |
| OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | 10MG | TABLET;ORAL |
2 products